Abstract
Precision modification of antibodies with bone-targeting moieties unleashes their potential for the treatment of bone metastases.
All Related Versions
Funding Information
  • National Institutes of Health (GM133706)
  • National Institutes of Health (CA255894)
  • National Institutes of Health (CA183878)
  • National Institutes of Health (CA221946)
  • U.S. Department of War (W81XWH-16-1-0073)
  • U.S. Department of War (BC201371)
  • U.S. Department of War (DAMD W81XWH-16-1-0073)
  • Welch Foundation (C-1970)
  • Cancer Prevention and Research Institute of Texas (RR170014)
  • John S. Dunn Foundation Collaborative Research
  • Hamill Innovation Award
  • National Cancer Institute (CA183878)
  • National Cancer Institute (CA221946)

This publication has 49 references indexed in Scilit: